rs41285470

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_020806.5(GPHN):ā€‹c.800A>Gā€‹(p.Asn267Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.007 in 1,608,422 control chromosomes in the GnomAD database, including 59 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.0059 ( 2 hom., cov: 32)
Exomes š‘“: 0.0071 ( 57 hom. )

Consequence

GPHN
NM_020806.5 missense

Scores

15

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.305
Variant links:
Genes affected
GPHN (HGNC:15465): (gephyrin) This gene encodes a neuronal assembly protein that anchors inhibitory neurotransmitter receptors to the postsynaptic cytoskeleton via high affinity binding to a receptor subunit domain and tubulin dimers. In nonneuronal tissues, the encoded protein is also required for molybdenum cofactor biosynthesis. Mutations in this gene may be associated with the neurological condition hyperplexia and also lead to molybdenum cofactor deficiency. Numerous alternatively spliced transcript variants encoding different isoforms have been described; however, the full-length nature of all transcript variants is not currently known. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0040991902).
BP6
Variant 14-66924264-A-G is Benign according to our data. Variant chr14-66924264-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 466213.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-66924264-A-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00587 (894/152294) while in subpopulation AMR AF= 0.011 (168/15292). AF 95% confidence interval is 0.00963. There are 2 homozygotes in gnomad4. There are 453 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GPHNNM_020806.5 linkuse as main transcriptc.800A>G p.Asn267Ser missense_variant 8/23 ENST00000478722.6 NP_065857.1 Q9NQX3-2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GPHNENST00000478722.6 linkuse as main transcriptc.800A>G p.Asn267Ser missense_variant 8/231 NM_020806.5 ENSP00000417901.1 Q9NQX3-2

Frequencies

GnomAD3 genomes
AF:
0.00587
AC:
893
AN:
152176
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00171
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0110
Gnomad ASJ
AF:
0.00635
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.00650
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.00775
Gnomad OTH
AF:
0.00717
GnomAD3 exomes
AF:
0.00653
AC:
1641
AN:
251212
Hom.:
10
AF XY:
0.00664
AC XY:
902
AN XY:
135750
show subpopulations
Gnomad AFR exome
AF:
0.00160
Gnomad AMR exome
AF:
0.00721
Gnomad ASJ exome
AF:
0.00486
Gnomad EAS exome
AF:
0.000163
Gnomad SAS exome
AF:
0.00451
Gnomad FIN exome
AF:
0.00823
Gnomad NFE exome
AF:
0.00822
Gnomad OTH exome
AF:
0.0104
GnomAD4 exome
AF:
0.00712
AC:
10372
AN:
1456128
Hom.:
57
Cov.:
28
AF XY:
0.00707
AC XY:
5127
AN XY:
724764
show subpopulations
Gnomad4 AFR exome
AF:
0.00141
Gnomad4 AMR exome
AF:
0.00739
Gnomad4 ASJ exome
AF:
0.00525
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.00488
Gnomad4 FIN exome
AF:
0.00983
Gnomad4 NFE exome
AF:
0.00751
Gnomad4 OTH exome
AF:
0.00813
GnomAD4 genome
AF:
0.00587
AC:
894
AN:
152294
Hom.:
2
Cov.:
32
AF XY:
0.00608
AC XY:
453
AN XY:
74474
show subpopulations
Gnomad4 AFR
AF:
0.00171
Gnomad4 AMR
AF:
0.0110
Gnomad4 ASJ
AF:
0.00635
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00291
Gnomad4 FIN
AF:
0.00650
Gnomad4 NFE
AF:
0.00775
Gnomad4 OTH
AF:
0.00710
Alfa
AF:
0.00746
Hom.:
6
Bravo
AF:
0.00564
TwinsUK
AF:
0.00809
AC:
30
ALSPAC
AF:
0.00597
AC:
23
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.00756
AC:
65
ExAC
AF:
0.00640
AC:
777
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.0106
EpiControl
AF:
0.00884

ClinVar

Significance: Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Likely benign, criteria provided, single submitterclinical testingGeneDxFeb 10, 2021- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenFeb 01, 2024GPHN: BP4, BS2 -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A Benign:2
Likely benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Likely benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, University Medical Center UtrechtAug 31, 2015- -
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C;C4551954:Hyperekplexia 1 Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 13, 2021- -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsApr 08, 2022This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 30, 2024- -
GPHN-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesSep 04, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
0.048
DANN
Benign
0.44
Eigen
Benign
-1.1
Eigen_PC
Benign
-0.99
FATHMM_MKL
Benign
0.082
N
LIST_S2
Benign
0.75
T;T
MetaRNN
Benign
0.0041
T;T
MetaSVM
Benign
-1.1
T
PrimateAI
Benign
0.28
T
PROVEAN
Benign
0.32
N;N
REVEL
Benign
0.089
Sift
Benign
1.0
T;T
Sift4G
Benign
0.70
T;T
Polyphen
0.0
B;B
Vest4
0.11
MVP
0.12
MPC
0.51
ClinPred
0.0018
T
GERP RS
-6.2
gMVP
0.32

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs41285470; hg19: chr14-67390981; API